Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kevzara (sarilumab)
Pharma
Regeneron, Sanofi's Kevzara nabs polymyalgia rheumatica FDA nod
With the approval, Kevzara becomes the first biologic drug for polymyalgia rheumatica.
Zoey Becker
Mar 1, 2023 1:03pm
Regeneron buys rights to Libtayo from Sanofi for $900M
Jun 2, 2022 10:14am
WHO says yes to arthritis drugs for use against severe COVID-19
Jul 7, 2021 11:53am
Actemra and Kevzara slash risk of COVID-19 deaths by 24%: study
Jan 8, 2021 10:34am
Streamlining Sanofi mulls drug sale that could snare $234M
Oct 19, 2020 10:10am
Sanofi, Regeneron pull the plug on Kevzara in COVID-19
Sep 1, 2020 10:55am
